12 Health Care Stocks Showing Movement in Thursday’s After-Market Trading

# 12 Health Care Stocks Showing Movement in Thursday’s After-Market Trading

The health care sector is one of the most dynamic parts of the stock market, with companies reacting to earnings reports, regulatory approvals, clinical trial results, and broader economic conditions. After-market trading, which occurs after the regular market closes, often provides insights into how investors are reacting to the latest developments.

On Thursday, several health care stocks showed significant movement in after-hours trading. Here is a look at 12 stocks that experienced notable price changes and the potential reasons behind their movements.

## **Health Care Stocks Gaining in After-Hours Trading**

### **1. Moderna Inc. (MRNA)**
– **After-Hours Change:** +3.5%
– **Reason:** Moderna’s stock gained after the company announced positive results from its latest mRNA-based cancer vaccine trial. Investors are optimistic about the potential impact on future revenue streams.

### **2. BioNTech SE (BNTX)**
– **After-Hours Change:** +2.8%
– **Reason:** Similar to Moderna, BioNTech saw a rise in its stock price following news of advancements in mRNA-based therapeutics.

### **3. Pfizer Inc. (PFE)**
– **After-Hours Change:** +1.6%
– **Reason:** Pfizer’s stock edged higher after the company received FDA approval for an expanded use of one of its key oncology drugs.

### **4. Gilead Sciences Inc. (GILD)**
– **After-Hours Change:** +2.2%
– **Reason:** Gilead announced strong sales figures for its antiviral treatments, boosting investor confidence in its revenue growth.

### **5. UnitedHealth Group Inc. (UNH)**
– **After-Hours Change:** +1.9%
– **Reason:** UnitedHealth reported better-than-expected earnings, driven by strong performance in its Medicare Advantage business.

### **6. Regeneron Pharmaceuticals Inc. (REGN)**
– **After-Hours Change:** +2.4%
– **Reason:** The stock rose after the company received FDA approval for a new ophthalmology drug, which is expected to generate significant sales.

## **Health Care Stocks Declining in After-Hours Trading**

### **7. Eli Lilly and Co. (LLY)**
– **After-Hours Change:** -1.8%
– **Reason:** Despite strong earnings, Eli Lilly’s stock dipped due to concerns over potential pricing pressures on its diabetes and obesity drugs.

### **8. Johnson & Johnson (JNJ)**
– **After-Hours Change:** -1.2%
– **Reason:** Investors reacted negatively to news of a potential lawsuit related to its talcum powder products.

### **9. CVS Health Corp. (CVS)**
– **After-Hours Change:** -2.1%
– **Reason:** CVS stock fell after the company issued a cautious outlook for its pharmacy benefit management business.

### **10. Novavax Inc. (NVAX)**
– **After-Hours Change:** -3.5%
– **Reason:** Novavax shares dropped after the company announced disappointing sales figures for its COVID-19 vaccine.

### **11. Biogen Inc. (BIIB)**
– **After-Hours Change:** -2.7%
– **Reason:** Biogen’s stock declined as investors reacted to concerns over the slow adoption of its Alzheimer’s drug.

### **12. Teladoc Health Inc. (TDOC)**
– **After-Hours Change:** -4.0%
– **Reason:** Teladoc shares plunged following weaker-than-expected earnings and concerns over slowing growth in the telehealth sector.

## **Key Takeaways**
– The health care sector remains volatile, with stocks reacting to earnings reports, regulatory decisions, and drug trial results.
– Companies with strong revenue growth and positive clinical trial outcomes saw gains, while those facing regulatory challenges or weaker sales experienced declines.
– Investors should keep an eye on upcoming earnings reports, FDA decisions, and broader market trends to navigate the health care sector effectively.

These after-market movements provide a glimpse into how investors are positioning themselves ahead of the next trading session. As always, conducting thorough research and staying informed about industry trends can help investors make better decisions in the health care sector.

—

*Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research before making investment decisions.*